Intraocular pressure (IOP) reduction by medications, laser, or surgery remains the mainstay of treatment in glaucoma. However, the role of complementary and alternative medicine (CAM) in glaucoma has received great interest from both patients and ophthalmologists. Previous evidence suggests that diet, a major domain of CAM, can influence an individual's IOP level. Furthermore, certain dietary components have been linked to the incidence and progression of glaucoma. In this review, we aim to provide a summary of the current evidence regarding the role of obesity, certain dietary components, and dietary supplements in glaucoma.
INTRODUCTION
Glaucoma is a major cause of irreversible blindness worldwide. Globally, it is estimated that 5.7 million people are visually impaired as a result of glaucoma [1] . Increased intraocular pressure (IOP) is the most significant risk factor in glaucoma [2] ; however, recent research on the pathogenesis of glaucoma suggests that non-IOP-dependent mechanisms also play a role. Vascular dysregulation [3] , oxidative stress [4] , autoimmunity [5] , and excitotoxicity [6] are all mechanisms that can explain why glaucomatous optic neuropathy may occur despite normal IOP.
IOP reduction is currently the mainstay of glaucoma treatment. It has been shown that IOP reduction significantly delays glaucoma progression by means of optic disc damage and visual field loss [7] . This is usually achieved by anti-glaucoma medications, laser therapy, or surgical intervention. Recently, a considerable amount of glaucoma research has been directed towards therapeutic approaches targeting non-IOP-dependent mechanisms. The effect of novel therapeutic agents [8] [9] [10] and complementary medications [11] [12] [13] targeting such pathways is a subject of attention.
The use of complementary and alternative medicine (CAM), targeting both IOP-dependent and non-IOP-dependent mechanisms, in glaucoma has received interest from some ophthalmologists [14] and glaucoma patients [15] . A report from Canada showed that one in every nine patients with glaucoma uses CAM in the treatment of his condition [16] . This encompasses a wide range of CAM categories, e.g. herbs, dietary interventions, exercise, and bodybased practices.
A major domain of CAM in glaucoma is the utilization of dietary interventions. A considerable amount of research suggests that an individual's diet may have an effect on IOP [17], the incidence of glaucoma [18] , and progression of the disease [19] . Furthermore, glaucoma patients commonly inquire about what to eat and drink in order to help in the treatment of their disease, and whether or not their dietary habits will affect the progression of their condition. Although it seems simple, an answer to such question is yet to be determined by ongoing research in this arena.
The objective of this review was to provide a summary of the current evidence regarding the effect of obesity and diet on IOP, incidence, and progression of glaucoma. The review outlines three major elements pertinent to diet: obesity and energy intake, individual dietary components, and dietary supplements.
METHODS
A literature review using the advanced search builder on PubMed was made in December 2017. The following search technique was implemented; ''glaucoma'' or ''IOP'' along with all of the following keywords: diet, nutrition, obesity, body mass index, alcohol, coffee, caffeine, tea, Ginkgo biloba extract, fruits, vegetables, chocolate, saffron, dietary supplements, and antioxidants. Search results were evaluated for relevance to our current review. Additional studies were added by manually reviewing bibliographies of articles obtained during the initial search. Results were limited to studies written in English, and published during the period from 1966 to 2017. In order to maintain clinical relevance, the main focus was on epidemiological and clinical studies conducted on human subjects.
This article is based on previously conducted studies and does not involve any new studies of human or animal subjects performed by any of the authors. Although BMI is a commonly used indicator of obesity, it has some limitations. A major drawback is that it does not differentiate between fat and muscle, such that it does not reflect the actual amount of fat tissue. In an attempt to overcome this, some studies have looked into the influence of other obesity markers on IOP [20, 36, 37] . The Korea National Health and Nutrition Examination Survey [36] found a positive linear relationship between different obesity markers (i.e. waist circumference, total body fat mass, and fat percentage) and IOP. Other reports have also found similar results on variable markers [20, 37] .
OBESITY AND ENERGY INTAKE
In addition to obesity, other components of metabolic syndrome (MetS) have also been linked to elevated IOP and glaucoma. In a retrospective review of 12,747 subjects, Wygnanski-Jaffe et al. [38] 
INDIVIDUAL DIETARY COMPONENTS

Alcohol
It has been shown that alcohol lowers IOP following acute ingestion in both glaucoma patients and healthy subjects [41, 42] . The exact mechanism leading to such finding is poorly understood; however, it is thought to be secondary to variable physiological changes such as a hyperosmotic effect exerted by alcohol, reduction of net water movement into the eye through vasopressin suppression [43] , and inhibition of secretory cells in the ciliary processes [44] . Moreover, alcohol was shown to increase blood flow to the optic nerve head, a mechanism that is thought to offer a protective effect against the development of POAG [45] .
With this in mind, various epidemiological studies were conducted to investigate the relation between alcohol consumption and glaucoma. Contrary to what is expected, the majority of those studies did not report any association [33, [46] [47] [48] Although elevated IOP is a well-established risk factor in POAG, studies looking into the connection between caffeine consumption and the incidence of POAG did not establish any association [59, 60] . However, Pasquale et al. [61] reported a positive association between caffeine consumption and the likelihood of developing pseudoexfoliative glaucoma in a large cohort of patients. Such association is assumed to be secondary to a caffeine-induced elevation in homocysteine levels [62, 63] , which is thought to be a trigger stimulating the formation of basement membrane material [64] .
Tea
The nutritional value of tea is derived from its major constituents (i.e. polyphenols, caffeine, and minerals) [65] . Flavonoids, a major polyphenol in tea, are thought to play a role in glaucoma [13, 66] owing to their various physiological actions that are proposed to affect non-IOP-dependent mechanisms. Studies have shown that flavonoids demonstrate their protective effect by reducing oxidative stress [67] and improving blood flow [68] .
The available evidence on the relation between tea consumption, outside the context of caffeine intake, and the incidence of glaucoma is scarce. Wu et al. [60] recently published a cross-sectional report from the National Health and Nutrition Examination Survey in the USA on the association between glaucoma and commonly consumed beverages. Their results have demonstrated that participants consuming at least one cup of hot tea daily are less likely to have glaucoma compared to their non-consuming counterparts.
Ginkgo biloba Extract
Ginkgo biloba extract (GBE) has been tested in the treatment of various medical conditions [69] , including glaucoma [70, 71] . GBE exhibits a myriad of pharmacological properties making it relevant to the pathogenesis of glaucoma. The current evidence suggests that GBE increases ocular blood flow [72] , improves retinal ganglion cell survival [73] , and protects against oxidative stress [74] .
Based on the fact that reduced ocular blood flow is thought to be a major player in the pathogenesis of normal tension glaucoma (NTG) [75] , multiple studies have looked into the effect of GBE on patients with NTG. Park JW, et al. [76] proved that GBE intake improves retinal blood flow in the peri-papillary region among patients with NTG. Moreover, multiple reports agree that GBE improves visual function [77, 78] , and slows the progression of visual field damage [19] in NTG. Conversely, a clinical trial from China found no effect on newly diagnosed patients with mild visual field loss [79] .
Fruits and Vegetables
Being rich in antioxidants, it is speculated that a diet rich in fruits and vegetables can decrease the risk of developing glaucoma. However, the nutrient composition of different fruits and vegetables varies, making it difficult to link the presumed protective effect to a single source. Nonetheless, multiple cross-sectional studies were conducted using food frequency questionnaires in an attempt to link certain fruits and vegetables to glaucoma. Coleman et al. [80] found a decreased glaucoma risk in women who consumed fruits and vegetables rich in vitamin A and carotenes, namely collard greens, kale, carrots, and peaches. Another study by Giaconi et al.
[18] also concluded that there is a decreased likelihood of glaucoma among women that reported a greater intake of fruits and vegetables rich in vitamins A and C, and carotenes.
Moreover, nitric oxide (NO) is thought to be a major contributor to vascular dysregulation in patients with POAG [81] . Therefore, it is hypothesized that high consumption of dietary nitrates might have a protective effect against the development of POAG. In a prospective cohort, Kang et al. [82] found that a diet rich in nitrates and green leafy vegetables was associated with a lower risk of developing POAG.
Chocolate
Dark chocolate is a rich dietary source of polyphenol compounds, specifically flavonoids [83] . Acute consumption of dark chocolate has been shown to reverse vascular endothelial dysfunction by decreasing oxidative stress and increasing the bioavailability of NO [84] . Therefore, it is proven beneficial in patients with certain cardiovascular diseases such as HTN [85] and peripheral artery disease [86] .
In glaucoma, the only trial looking into the effect of dark chocolate was published by Terai et al. [87] . Their study showed that acute consumption of dark chocolate increased retinal vessel diameter in healthy subjects, but not in glaucoma patients. A possible explanation of such finding is a compromised ability of the vascular endothelium to produce NO in patients with glaucoma. In spite of that, further research is still required to properly outline the role of dark chocolate in glaucoma.
Saffron
The only published study on the relation between IOP and saffron comes from Iran, the world's largest saffron exporter. Jabbarpoor Bonyadi et al. [88] studied the effect of a daily oral saffron capsule on IOP in patients with POAG. After a period of 3 weeks, a statistically significant decline in IOP was noted among the study group. They suggested that this hypotensive action is secondary to the antioxidative effect of saffron [89] on dysfunctional trabecular meshwork. However, due to limited experimental data, the exact mechanism remains unclear. Table 1 summarizes key findings from all the cited studies providing evidence regarding the effect of individual dietary components on IOP and glaucoma. [51] Case-control 100 OHT patients, 100 controls Absence of alcohol intake was significantly associated with OHT 
DIETARY SUPPLEMENTS
The benefit of dietary supplements is wellestablished in the management of patients with age-related macular degeneration [90, 91] ; however, in glaucoma, we still lack supporting evidence. A considerable amount of research suggests that levels of oxidative markers are altered in the plasma [92] [93] [94] [95] [96] [97] and aqueous [98, 99] of patients with POAG [95, 99] , as well as different types of glaucoma [92] [93] [94] . Therefore, it is hypothesized that the use of dietary supplements rich in antioxidants might play a role in glaucoma. Wang et al. [100] looked at the relation between the prevalence of glaucoma and the use of dietary supplements containing antioxidant vitamins (i.e. A, C, and E) among participants of the National Health and Nutrition Examination Survey. They also obtained measurements of serum vitamin levels to correlate them with the intake of supplements. No relation was found between reported glaucoma and supplemental use, or serum levels, of vitamins A and E. On the other hand, the supplemental intake of vitamin C was linked to a decreased chance of glaucoma; however, this did not correlate with serum vitamin C levels.
To date, the only prospective randomized clinical trial evaluating the possible effect of antioxidant supplements in glaucoma was published by Garcia-Medina et al. [101] . They studied the effect of the Age-Related Eye Disease Study (AREDS) formula on a small sample of patients with mild to moderate POAG. After 2 years of follow up, there was no difference in outcome between the studied groups.
Moreover, the possible role of long-chain polyunsaturated fatty acids has also been explored in the literature. A fatty acid imbalance between omega-3 and omega-6 is believed to contribute to the pathogenesis of POAG [102] . Furthermore, epidemiological studies assessing the dietary consumption of fatty acids have suggested that an imbalance in the omega-3-to-omega-6 ratio might be associated with an increased risk of developing glaucoma [103, 104] . However, in the trial conducted by Garcia-medina et al. [101] , the addition of 
CONCLUSION
The current level of evidence suggests that an individual's diet might have an impact on IOP, incidence, and progression of glaucoma. Given that the majority of results are drawn from observational studies, well-designed, randomized, controlled, clinical trials are required to reinforce the current body of evidence. A sound dietary advice to glaucoma patients would be to maintain a normal weight, avoid excessive coffee consumption, and increase the intake of fruits and vegetables. However, patients should be advised that nutritional management may complement, but would not substitute conventional glaucoma treatment.
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